JAN ANDERS AKERVALL
Pharmacy in Ann Arbor, MI
License number
Michigan 4301075498
Expiration Date
Jan 31, 2002
Category
Pharmacy
Type
CS - 1
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about JAN ANDERS AKERVALL at radaris.comName
Address
Phone
1131 Olivia Ave, Ann Arbor, MI 48104
2915 Ward Ct, Ann Arbor, MI 48108
2915 Ward Ct, Ann Arbor, MI 48108
28300 Orchard Lake Rd, Farmington Hills, MI 48334
5520 Stone Valley Dr, Superior Township, MI 48105
Professional information
Custom-Formable Mouth Guard And Method Of Fabrication
US Patent:
2009003, Feb 12, 2009
Filed:
Aug 11, 2008
Appl. No.:
12/228179
Inventors:
Jan Akervall - Ann Arbor MI, US
Johannes W. Schwank - Ann Arbor MI, US
Johannes W. Schwank - Ann Arbor MI, US
International Classification:
A61C 5/14
US Classification:
128861
Abstract:
A mouth guard composed of a polymer consisting essentially of polycaprolactone exhibits a low softening point, enabling it to be easily custom-fitted by the user or a health professional. The material is provided in the form of a generally U-shaped, unformed sheet of material, enabling the material to be heated with hot water or microwave energy and custom-fitted to the dentition of a user. The mouth guard may be perforated and may include a no-stick layer and/or a flavoring agent. A plurality of mouth guards may be provided in different sizes for children and adults and different shapes for different sports. In the preferred embodiments the mouth guard has a periphery including a plurality of lobes and cusps to enhance fitting. A method of fabricating an improved mouth guard according to the invention is also disclosed.
Method Of Using Biomarkers
US Patent:
2011026, Oct 27, 2011
Filed:
Oct 22, 2009
Appl. No.:
13/126129
Inventors:
Jan Akervall - Ann Arbor MI, US
International Classification:
C40B 30/00, H01J 49/26, G01N 21/64, C12Q 1/68, G01N 33/566
US Classification:
506 7, 435 611, 435 721, 435 71, 436501, 250282
Abstract:
The present invention provides methods and compositions for predicting patient responses to cancer treatment using the biomarkers: YAP-1, bcl-2, VEGF-c, c-met, and claudin-4.